Hello and welcome to my Nuzzel newsletter!
I'm Ronny, International Neuroendocrine Cancer Advocate. Independent Patient Voice. Award winning WEGO Health Patient Leader, Cure Today Contributor, Featured 1 million + Blogger (@netcancerblog).
– Oct 5, 2015, 6:16 AM
Neuroendocrine Cancers can sometimes present with one or more vague symptoms which occasionally results in a lengthy diagnostic phase for some. Sure, there can be issues with doctor experience and knowledge that can add to the problem. However…
ASHINGTON — The Food and Drug Administration has approved the first artificial intelligence software that can interpret images without a clinician's involvement, the agency announced Wednesday. The software, called IDx-DR, looks for diabetic…
On Wednesday the US Food and Drug Administration gave permission to a company called IDx to market the first diagnostic device that uses artificial intelligence. The approval marks medicine's entrance into an era of “diagnosis by…
by Ronny Allan, NET Patient Activist Doctors and scientists are always looking for better ways to care for patients with cancer; they are looking for a cure. Cancer research is currently running at full speed, taking advantage of all the…
– Feb 24, 2017
Do clinicians have accurate expectations of the benefits and harms of treatments and screening tests? A new study in JAMA Internal Medicine concludes not. In a systematic review of 48 studies (13 011 clinicians), the researchers found that…
– Jan 18, 2017, 1:16 PM
Here's some extracts from the CEO of Advanced Accelerator Applications 2016 Progress Report published on 9 Jan 2017. I've added additional comment where necessary to provide a richer picture. There is some really useful information, particularly…
– Feb 15, 2016, 12:32 PM
It was wet, windy and very cold and that was at the bottom of the hill I'm looking up at. It wasn't a terribly big hill but I knew it would need considerable effort and perhaps some temporary pain. Whilst the rain splashed onto our jackets and the…
Ronny Allan - Living with Neuroendocrine Cancer
– May 8, 2017, 12:05 PM
There's a lot of questions doing the rounds on forums and messages about the approval of Lutathera (PRRT) in USA, Europe and other places. This is not a place just for one particular country, I want a place to review what is happening globally…